Abstract
After a brief description of the clinical characteristics of hepatic metastases from gastric cancer and their different clinical settings, we discuss the natural evolution of the disease, focusing on the extremely poor prognosis of these patients. Through a complete review of the literature, the chapter provides detailed insight into the different therapeutic options, discussing their indications, patient selection criteria, and results. We argue that a correct therapeutic approach can offer to a relatively large percentage of patients (≈ 40%) an unexpected 20–40% 5-year survival rate. Our main purpose is to convey the cultural basis that will induce the reader to reconsider the largely predominating passive attitude toward these patients by acknowledging the opportunity to offer better and longer survival to a selected subgroup.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dicken BJ, Bigam DL, Cass C et al (2005) Gastric adenocarcinoma. Review and considerations for future directions. Ann Surg 241:27–39
D’Angelica M, Gonen M, Brennan MF et al (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240:808–816
Tiberio GAM, Coniglio A, Marchet A et al (2009) Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. EJSO 35:486–491
Marrelli D, Roviello F, De Stefano A et al (2004) Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. J Am Coll Surg 198:51–58
Japanese Gastric Cancer association (1998) Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer 1:10–24
Cocconi G, Carlini P, Gamboni A et al (2003) Cisplatin, epirubicin, leucovorin and 5-fluorourail (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma. Ann Oncol 14:1258–1263
Lee J, Kang WK, Kwon JM et al (2007) Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma. Ann Oncol 18:88–92
Cao W, Yang W, Lou G et al (2009) Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer. Anticancer Drugs 20:287–293
Yoshida M, Ohtsu A, Boku N et al (2004) Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. JJCO 34:654–659
Okano K, Maeba T, Ishimura K et al (2002) Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235:86–91
Ambiru S, Miyazaki M, Ito H et al (2001) Benefits and limits of hepatic resection for gastric metastases. Am J Surg 181:279–283
Kerkar SP, Kemp CD, Avital I (2010) Liver resections in metastatic gastric cancer. HPB 12:589–596
Chiche L, Ducreux M, Lebreton G et al (2005) Métastases hépatiques des cancers de l’estomac. In: Adam R, Chiche L, eds. Chirurgie des métastases hépatiques de cancers non colorectaux non endocrine. Monographies de l’association Française de Chirurgie. Arnette, Paris pp 45–59
Ochiai T, Sasako M, Mizuno S et al (1994) Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81:1175–1178
Miyazaki M, Itoh H, Nakagawa K et al (1997) Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 92:490–493
Fujii K, Fujioka S, Kato K et al (2001) Resection of liver metastasis from gastric adenocarcinoma. Hepatogastroenterology 48:368–371
Imamura H, Matsuyama Y, Shimada R et al (2001) A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 96:3178–3184
Zacherl J, Zacherl M, Scheuba C et al (2002) Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 6:682–689
Saiura A, Umekita N, Inoue S et al (2002) Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 49:1062–1065
Shirabe K, Shimada M, Matsumata T et al (2003) Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology 50:1560–1563
Roh HR, Suh KS, Lee HJ et al (2005) Outcome of hepatic resection for metastatic gastric cancer. Am Surg 71:95–99
Sakamoto Y, Sano T, Shimada K et al (2007) Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 95:534–539
Koga R, Junji Y, Shigekazu O et al (2007) Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. JJCO 37:836–842
Tsujimoto H, Ichikura T, Ono S et al (2010) Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int 4:406–413
Cheon SH, Rha SY, Jeung H-C et al (2008) Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Onc 19:1146–1153
Makino H, Kunisaki C, Izumisawa Y et al (2010) Indication for hepatic resection in the treatment of liver metastasis from gastric cancer. Anticanc Res 30:2367–2376
Ueda K, Iwahashi M, Nakamori M et al (2009) Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer. Langenbecks Arch Surg 394:647–653
Adam R, Chiche L, Aloia T et al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases. Ann Surg 244:524–535
Hwang S-E, Yang D-H, Kim C-Y (2009) Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer. World J Surg 33:1468–1472
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Tiberio, G.A.M., Coniglio, A., Baiocchi, G.L., Giulini, S.M. (2012). Surgical Treatment of Liver Metastases from Gastric Cancer. In: de Manzoni, G., Roviello, F., Siquini, W. (eds) Surgery in the Multimodal Management of Gastric Cancer. Springer, Milano. https://doi.org/10.1007/978-88-470-2318-5_14
Download citation
DOI: https://doi.org/10.1007/978-88-470-2318-5_14
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2317-8
Online ISBN: 978-88-470-2318-5
eBook Packages: MedicineMedicine (R0)